Ipratropium bromide 0.5 mg/3 mL (0.017%), albuterol (as sulfate) 2.5 mg/3 mL (0.083%); soln for inh. Not for primary treatment of acute attack. Avoid excessive use. Discontinue if paradoxical ...
RIDGEFIELD, Conn., April 13 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" ...
As part of the company's commitment to chronic obstructive pulmonary disease (COPD) patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare ...
October 7, 2011 — The US Food and Drug Administration (FDA) has granted approval for an ipratropium bromide and albuterol sulfate inhalation spray (Combivent Respimat Inhalation Spray, Boehringer ...
COMBIVENT MDI and COMBIVENT RESPIMAT are the only short-acting bronchodilator products that offer two different medicines in a single inhaler. Clinical studies in patients with COPD have shown that ...
Fri, 18 Sep 2009 12:51:42 GMT — The FDA Warns Consumers Not to Use Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution. The U.S. Food and Drug Administration today ...
To earn CME related to this news article, click here. March 4, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to provide additional counseling information for ...
Review the side-effects of Albuterol and Ipratropium as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...
Two asthma inhalers are being phased out, the Food and Drug Administration announced at the end of May. The Combivent Inhalation Aerosol and the Maxair Autohaler both contain chlorofluorocarbons (CFCs ...
Novel drug effective for asthma, COPD Higher cost, longer treatment time associated with BAN for adults with wheezing, dyspnea. HealthDay News — Treating adults with wheezing or dyspnea with a ...
JERUSALEM The Food and Drug Administration has granted final approval to Teva Pharmaceuticals for its application for a generic version of Dey’s drug DuoNeb. DuoNeb is a bronchodilator that increases ...
Masala Mayhem: After Baby Products, Food Authority To Scrutinize Spices Sold In India In accordance with the latest Enforcement Report from the US Food and Drug Administration (USFDA), Cipla's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback